Literature DB >> 29213745

Neuropsychiatric symptoms as the main determinant of caregiver burden in Alzheimer's disease.

Renata Kochhann1,2, Ericksen Borba1,2, Maria Otília Cerveira1, Diego Onyszko1, Alyne de Jesus1, Letícia Forster1, Luisa Franciscatto1, Cláudia Godinho1,2, Ana Luiza Camozzato1,2,3, Márcia Lorena F Chaves1,2,4.   

Abstract

Caregiver burden is common in Alzheimer's disease (AD), decreasing the quality of life among caregivers and patients. Projections of aging and aging-related diseases such as AD in developing countries justify additional data about this issue because people living in these countries have shown similarly high levels of caregiver strain as in the developed world.
OBJECTIVE: The aim of this study was to analyze the association of AD caregivers' burden with patients' neuropsychiatric symptoms (NPS), cognitive status, severity of dementia, functional capacity, caregiver sociodemographic characteristics, and the characteristics of care provided by caregivers.
METHODS: A cross-sectional study was conducted in a sample of 39 consecutive AD patients and their primary caregivers. NPS were evaluated using the Neuropsychiatric Inventory (NPI). Severity of dementia was assessed with the Clinical Dementia Rating (CDR) scale. Functional capacity was assessed using the Katz and Lawton scales. The burden level was rated using the Burden Interview (BI). Sociodemographic characteristics of caregivers and the characteristics of care provided by them were evaluated. The Mann-Whitney U-test, Kruskal-Wallis test and Spearman's rho coefficient were performed.
RESULTS: The BI had a moderate correlation with NPI intensity (rho=0.563), p<001. Female caregivers reported a greater level of burden (p=0.031) than male caregivers. The other variables were not significantly associated to caregiver burden.
CONCLUSION: NPS were the main determinant of burden in primary caregivers of AD patients. This result underscores the need for prevention and treatment of these symptoms. Sex also had an effect on caregiver burden, but the small male sample in this study precludes the generalization of this finding.

Entities:  

Keywords:  Alzheimer’s disease patients; caregiver burden; neuropsychiatric symptoms

Year:  2011        PMID: 29213745      PMCID: PMC5619480          DOI: 10.1590/S1980-57642011DN05030008

Source DB:  PubMed          Journal:  Dement Neuropsychol        ISSN: 1980-5764


Alzheimer’s disease (AD) is stressful for those who acquire it, and also for the caregivers of these patients. Some characteristics have been studied to determine caregiver burden including severity of the dementia, behavioral problems and patient’s activities of daily living; age of caregiver, problem-solving ability and perception of disease by caregivers; financial resources, social support, cognitive and functional impairment of patients.[1] Studies on the care arrangements for people with dementia living in developing countries have shown that levels of caregiver strain were at least as high as in the developed world.[2] Therefore, the projections of aging and aging-related diseases such as AD in these regions justify the search for additional data about this issue. In a previous evaluation by our group, no relationship was found between caregiver demographic variables and caregiver distress (evaluated with the Neuropsychiatric Inventory-Distress scale - NPI-D).[3] As NPI-D analyzes distress related to specific neuropsychiatric symptoms it was decided to evaluate burden in general (using the Zarit Burden Interview - BI) and to analyze the association between caregiver demographic characteristics and BI. However, we first hypothesized that caregivers from developing countries taking care of patients under the public health system, albeit in a university hospital, would be from lower social classes and exhibit higher levels of burden. We also hypothesized that the following characteristics would be associated with higher levels of burden: being in charge of patients with severe dementia; being a full time caregiver; and having lower educational attainment. Therefore, the aim of the study was to analyze the association of AD caregivers’ burden with patients’ neuropsychiatric symptoms, cognitive status, severity of dementia, functional capacity, caregiver sociodemographic characteristics, and the characteristics of care provided by caregivers.

Methods

A cross-sectional study was conducted in a sample of 39 consecutive patients and their primary caregivers. Participants were enrolled from the Dementia Clinic of Hospital de Clinicas de Porto Alegre (a public university hospital) after giving informed consent. Primary caregiver was defined as someone who spent at least 20h per week giving care. All patients fulfilled the DSM-IV criteria for dementia,[4] and the NINCDS-ADRDA criteria for probable Alzheimer’s disease.[5] For assessment of cognitive status, all patients underwent evaluation with the Mini Mental State Examination (MMSE).[6-8] Functional capacity was evaluated with the Katz and Lawton scales.[9,10] The severity of dementia was assessed using the Clinical Dementia Rating (CDR) scale.[11-13] The CDR evaluates memory, orientation, judgment and problem solving, community affairs, home and hobbies, and personal care. This instrument allows the clinicians to categorize patient disease into mild (CDR=1), moderate (CDR=2) or severe (CDR=3) dementia. Neuropsychiatric symptoms were evaluated using the Neuropsychiatric Inventory (NPI).[14,15] The NPI consists of three sections for each symptom: frequency, severity, and distress. The information was obtained from the caregiver who had observed the symptoms in the patient during a specific period. Each caregiver was asked an initial screening question for each of the 12 neuropsychiatric domains. If the screening question was negatively answered, the interviewer moved on to the next domain. If it was positively answered, further questions were asked, allowing scores for both severity (range: 1[mild]–3 [marked]) and frequency (range: 1[occasional]–4[very frequent]) of each symptom. An intensity score was then obtained by multiplying the scores of severity by frequency (range: 0–12 for each item). Burden was rated with the Burden Interview (BI).[16-18] BI consists of a 22-item questionnaire which verifies the burden perceived by the caregivers concerning: request for help from patients, lack of personal time, feeling of tiredness, embarrassment, irritation, tension, lack of privacy, feeling that the caregiver’s social life is impaired, among others. Questions from 1 to 21 are answered by assigning the following levels of frequency: never=0, rarely=1, sometimes=2, quite frequently=3, or nearly always=4. Question 22 assesses, in general terms, the burden felt by the caregiver and can be scored using the following alternatives: not at all=0, a little=1, moderately=2, quite a bit=3, extremely=4. Total scores range from 0 to 88, and the higher the score, the higher the level of burden. Caregivers’ demographic data and care characteristics (i.e., relationship with the patient - spouse, daughter/son, other relative, non relative -, self-reported number of hours per week spent giving care, time as caregiver, whether the caregiver lives with patient and whether the caregiver receives payment for care) were evaluated. Caregiver social class was also evaluated with a Brazilian scale which allows classification into A, B, C, D or E classes, where A is the highest level.[19]

Statistical analyses

Descriptive statistics (mean, SD and frequency) were calculated for demographic data, NPI scores of intensity, MMSE scores and BI total score. The Mann-Whitney U-test, Kruskal-Wallis test and Spearman’s rho coefficient were performed. The statistical analysis was performed using the Statistical Package for the Social Sciences (SPSS 18.0 for Windows).

Results

Demographic and clinical data from patients and caregivers are shown in Table 1.
Table 1

Clinical and demographic data of patients and caregivers.

VariablesAD patientsCaregivers
Sex N (%)  
    Female26 (67)31 (80)
    Male13 (33)8 (20)
CDR N (%)   
    113 (33)-
    213 (33)-
    313 (33)-
Relationship to patient   
    Spouse-11 (28)
    Daughter/son-27 (69)
    Other relative -1 (3)
Social class N (%)  
    A and B-25 (64)
    C, D and E-14 (36)
Full time job as caregiver N (%)  
    Yes-29 (74)
    No-10 (26)
Caregiver lives with patient N (%)-33 (85)
Caregiver is unpaid for care of patient N (%)-38 (97)
Time as caregiver in months* (range)-62.10±49.68 (7-216)
Caregiver hours per week* (range)-100.69±23.38 (25-112)
Age* (range)77.56±8.01 (52-90)52.90±13.11 (20-79)
Years of education* (range) 4.54±4.14 (0-16)10.08±4.79 (2-22)
MMSE* (range) 10.54±6.58 (0-24)-
NPI Intensity* (range)33.51±22.56 (0-82)-
ADL* (range)8.13±6.14 (0-18)_
IADL* (range)10.82±3.42 (3-14)_
BI* (range)-33.51±15.75 (3-68)

mean±SD

Clinical and demographic data of patients and caregivers. mean±SD BI presented moderate correlation with NPI intensity (rho=0.563), p<001. We also found similar distribution of NPS intensity among the different stages of dementia (severity) (Kruskal-Wallis U-test) (p=0.132). Other patient and caregiver variables showed no correlation with BI (i.e., age, education, time as caregiver, hours of care per week). The data for comparison of the BI scores according to category (i.e., sex, dementia severity, social class) is given in Table 2. Female caregivers had higher levels of burden (p=0.031) than male caregivers. No other categorical variable presented a statistically significant effect on caregiver BI scores.
Table 2

Analyses of BI scores on categorical variables.

VariablesBI mean±SDp value
Caregiver's sex*  
    Female36.19±16.11 
    Male23.13±8.930.031
Caregiver lives with patient*  
    Yes35.33±15.48 
    No23.50±14.480.106
Full time job as caregiver*  
    Yes34.28±15.82 
    No31.30±16.170.809
CDR**  
    133.08±19.64 
    233.85±11.67 
    334.62±16.130.796
Relationship to patient**  
    Spouse31.73±19.59 
    Daughter/son34.59±14.45 
    Other relative 24.000.618
Social class*  
    A and B31.92±13.88 
    C, D and E36.36±18.860.379
Caregiver's type of care*  
    Paid47.00 
    Unpaid33.16±15.800.286

Mann-Whitney Test;

Kruskal-Wallis Test.

Analyses of BI scores on categorical variables. Mann-Whitney Test; Kruskal-Wallis Test.

Discussion

This study evaluated the association of burden of AD caregivers with patients’ neuropsychiatric symptoms, cognitive status, dementia severity, functional capacity, caregiver sociodemographic characteristics, and characteristics of care provided by caregivers. The main finding was a positive correlation between burden scores and neuropsychiatric symptoms (NPS), suggesting that behavioral disturbances are a key-factor predisposing caregivers to distress, life disruptions, other physical and mental suffering. Other studies have previously reported this finding.[20-23] Low levels of informal social support,[20] decreased patient quality of life,[23] lower patient functional capability[23] and severity of cognitive decline[21] were also associated with higher levels of burden in theses studies. In a previous study by our group,[3] a significant correlation between total severity NPI and distress NPI was observed, but none of the caregiver demographic data were shown to be associated with distress. Taken together, previous and current results showed NPS to be correlated to distress and burden, independent of any specific neuropsychiatric or general symptoms. In the first study, apathy was the symptom responsible for the highest distress level, followed by agitation and aggression. The most frequent symptoms were apathy and aberrant motor behavior. Patients’ relatives also considered apathy as the most severe symptom, followed by depression and agitation.[3] In the present study, neither cognitive status or dementia severity was associated to levels of burden, supporting the notion that cognition and intensity of disease are not determinants of burden. Other patient and caregiver variables also showed no relationship with burden. However, sex had an effect on caregiver burden, but the small size of the male sample (N=8, 20%) prevents generalization of this finding. Individuals from developing countries taking care of patients, users of the public health system, albeit a university hospital were from lower social classes and had higher levels of burden. Besides lower financial means, inaccessibility to other resources could render these individuals more prone to burden. However, the findings of the present study failed to confirm this relationship. More than half of the sample (64%) pertained to upper classes according to the Brazilian classification, and the variability of burden was high. This Brazilian classification for social class may present a bias towards higher levels because it takes into account purchasing power together with educational attainment, but income is not adequately weighted. Despite being largely used this measure may introduce some degree of bias. The characteristics of being in charge of patients with severe dementia, being a full time caregiver, and having lower educational attainment were also not associated with higher burden. The distribution of the Burden Interview scores among dementia severity classes of patients was similar as were levels of neuropsychiatric symptoms (NPS) evaluated with the NPI, suggesting caregiver burden and patient intensity of neuropsychiatric symptoms may be independent of stage of disease (severity). The main objective of the study was to assess primary caregivers and therefore most of the individuals were fulltime carers since this reflects the most common profile in Brazil.[21] The present study showed a similar caregiver profile to Moscoso’s study.[21] One limitation of this investigation, besides the small sample size, was the lack of medical and personal variables from the caregiver such as depression, anxiety, and management strategies that could influence the perception of burden. Nevertheless, the objective of the study was the analysis of sociodemographic data, care and dementia-related characteristics. As neuropsychiatric symptoms are common in dementia and affect virtually all patients at some point in the course of the illness,[24,25] the prevention and treatment of these symptoms are needed. Concerns about the safety and efficacy of psychotropic medications have been raised. Despite these concerns, medications are often prescribed for neuropsychiatric symptoms.[26-28] Specific types of caregiver and residential care staff education, behavior management therapies, and possibly cognitive stimulation, appear to offer long-term effectiveness for the management of dementia-associated neuropsychiatric symptoms.[29]
  25 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Impaired awareness, behavior disturbance, and caregiver burden in Alzheimer disease.

Authors:  Susan Rymer; Stephen Salloway; Lauren Norton; Paul Malloy; Stephen Correia; Diane Monast
Journal:  Alzheimer Dis Assoc Disord       Date:  2002 Oct-Dec       Impact factor: 2.703

3.  [Suggestions for utilization of the mini-mental state examination in Brazil].

Authors:  Sonia M D Brucki; Ricardo Nitrini; Paulo Caramelli; Paulo H F Bertolucci; Ivan H Okamoto
Journal:  Arq Neuropsiquiatr       Date:  2003-10-28       Impact factor: 1.420

4.  STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

Authors:  S KATZ; A B FORD; R W MOSKOWITZ; B A JACKSON; M W JAFFE
Journal:  JAMA       Date:  1963-09-21       Impact factor: 56.272

5.  Dementia caregiver burden: reliability of the Brazilian version of the Zarit caregiver burden interview.

Authors:  Anita Taub; Sergio B Andreoli; Paulo H Bertolucci
Journal:  Cad Saude Publica       Date:  2004-04-06       Impact factor: 1.632

6.  Association between risperidone treatment and cerebrovascular adverse events: examining the evidence and postulating hypotheses for an underlying mechanism.

Authors:  David A Smith; Manju T Beier
Journal:  J Am Med Dir Assoc       Date:  2004 Mar-Apr       Impact factor: 4.669

7.  Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials.

Authors:  Eric Wooltorton
Journal:  CMAJ       Date:  2002-11-26       Impact factor: 8.262

8.  Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease.

Authors:  O L Lopez; S R Wisniewski; J T Becker; F Boller; S T DeKosky
Journal:  Arch Neurol       Date:  1999-10

9.  Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.

Authors:  Constantine G Lyketsos; Oscar Lopez; Beverly Jones; Annette L Fitzpatrick; John Breitner; Steven DeKosky
Journal:  JAMA       Date:  2002-09-25       Impact factor: 56.272

10.  Care arrangements for people with dementia in developing countries.

Authors:  Martin Prince
Journal:  Int J Geriatr Psychiatry       Date:  2004-02       Impact factor: 3.485

View more
  4 in total

1.  Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid.

Authors:  Victor Bloniecki; Dag Aarsland; Kaj Blennow; Jeffrey Cummings; Farshad Falahati; Bengt Winblad; Yvonne Freund-Levi
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

2.  Caregiver Reactions to Aggressive Behaviors in Persons With Dementia in a Diverse, Community-Dwelling Sample.

Authors:  Bryan R Hansen; Nancy A Hodgson; Chakra Budhathoki; Laura N Gitlin
Journal:  J Appl Gerontol       Date:  2018-02-19

3.  Utility of the Neuropsychiatric Inventory Questionnaire (NPI-Q) in the assessment of a sample of patients with Alzheimer's disease in Chile.

Authors:  Gada Musa; Fernando Henríquez; Carlos Muñoz-Neira; Carolina Delgado; Patricia Lillo; Andrea Slachevsky
Journal:  Dement Neuropsychol       Date:  2017 Apr-Jun

4.  Are neuropsychiatric symptoms in dementia linked to CSF biomarkers of synaptic and axonal degeneration?

Authors:  Victor Bloniecki; Henrik Zetterberg; Dag Aarsland; Patrizia Vannini; Hlin Kvartsberg; Bengt Winblad; Kaj Blennow; Yvonne Freund-Levi
Journal:  Alzheimers Res Ther       Date:  2020-11-17       Impact factor: 6.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.